1. The pathophysiology and current treatments for the subcutaneous panniculitis‐like T cell lymphoma: An updated review
   En‐Cheng Lin et al, 2023, Asia-Pacific Journal of Clinical Oncology CrossRef
2. Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis
   Wanying Cheng et al, 2023, Frontiers in Immunology CrossRef
3. Guillain-Barré syndrome and hemophagocytic syndrome heralding the diagnosis of diffuse large B cell lymphoma: A case report
   Qiao-Lin Zhou et al, 2022, World Journal of Clinical Cases CrossRef
4. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome
   Lanlan Zhou et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
5. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
   Liqiang Wei et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
6. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients
   Ailin Zhao et al, 2022, Frontiers in Immunology CrossRef
7. Prognostic Factors of Adult Hemophagocytic Lymphohistiocytosis and Clinical Utility of HLH-2004 Diagnostic Criteria and HScore: A Real-World Multicenter Study from Thailand
   Pitchayaporn Jongdee et al, 2024, Acta Haematologica CrossRef
8. Progress in Diagnosis and Treatment of Lymphoma-Associated Hemophagocytic Syndrome
   涵越 张, 2024, Advances in Clinical Medicine CrossRef